Cystargolides, 20S Proteasome Inhibitors Isolated from Kitasatospora Cystarginea
Overview
Affiliations
Two novel β-lactone-containing natural products, cystargolides A (1) and B (2), were isolated from the actinomycete Kitasatospora cystarginea. The production of these two natural products was highlighted using a methodology associating liquid chromatography-high-resolution mass spectrometry (LC-HRMS) analysis and the statistical analysis tool principal component analysis (PCA). Their structures were elucidated by interpretation of NMR experiments and tandem mass spectrometry. The absolute configurations of the amino acid residues were determined using Marfey's method, and the relative configurations of the β-lactone substituents were determined on the basis of the vicinal (3)J(HH) coupling value. Due to the presence of the β-lactone, 1 and 2 were evaluated for their ability to inhibit the human 20S proteasome. 1 and 2 both inhibited the 20S proteasome in vitro with IC50 values of 0.35 and 0.93 μM, respectively.
Cryptic enzymatic assembly of peptides armed with β-lactone warheads.
Xu G, Torri D, Cuesta-Hoyos S, Panda D, Yates L, Zallot R Nat Chem Biol. 2024; 20(10):1371-1379.
PMID: 38951647 PMC: 11427300. DOI: 10.1038/s41589-024-01657-7.
Biotechnological potential of actinomycetes in the 21st century: a brief review.
Rodrigues R, Souza A, Feitoza M, Alves T, Barbosa A, Santiago S Antonie Van Leeuwenhoek. 2024; 117(1):82.
PMID: 38789815 DOI: 10.1007/s10482-024-01964-y.
Cystargolide-based amide and ester Pz analogues as proteasome inhibitors and anti-cancer agents.
Viera C, Stevens B, Viera T, Zielinski C, Uranga L, Rogelj S R Soc Open Sci. 2022; 9(9):220358.
PMID: 36177203 PMC: 9515629. DOI: 10.1098/rsos.220358.
Shi Y, Hirschmann M, Shi Y, Ahmed S, Abebew D, Tobias N Nat Chem. 2022; 14(6):701-712.
PMID: 35469007 PMC: 9177418. DOI: 10.1038/s41557-022-00923-2.
Lu Q, Huang Y, Liu S, Wu G, Yang Q, Liu L Mar Drugs. 2021; 19(12).
PMID: 34940687 PMC: 8707991. DOI: 10.3390/md19120688.